ConductScience.org, home

Paper · 2250705

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Hockenbery D and 4 others. Nature, 1990. Cited by 3,653 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Papers, record 2250705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2250705

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
PubMed
Journal
Nature
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
3,653
iCite
Relative citation ratio, by iCite
87.1
iCite
Revised in PubMed
2025-02-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hockenbery DD
2Nuñez GG
3Milliman CC
4Schreiber RDR D
5Korsmeyer SJS J

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell SurvivalMajor topic
LymphomaMajor topic
Membrane ProteinsMajor topic
MitochondriaMajor topic
OncogenesMajor topic
Proto-Oncogene ProteinsMajor topic
Animals
Antibodies, Monoclonal
Base Sequence
Blotting, Western
Cell Line
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 18
Codon
Humans
Molecular Sequence Data
Open Reading Frames
Proto-Oncogene Proteins c-bcl-2
Translocation, Genetic

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by814

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,653 citations.

PMIDTitleJournalYearIn PapersSource
42,882,893Chk1/2 Inhibition by AZD7762 Enhances Andrographolide-Induced DNA Damage, Impairs DNA Repair, and Promotes Apoptosis in Head and Neck Squamous Cell Carcinoma CAL-33 Cells.Cancers (Basel)2026https://conductscience.org/library/papers/42882893PubMed
42,721,182N-acetylcysteine attenuates oxidative-stress-associated apoptosis and collagen deposition after rat hindlimb ischemia-reperfusion injury.PLoS One2026https://conductscience.org/library/papers/42721182PubMed
42,416,494Nephrotoxic acute kidney injury induced by Daboia siamensis venom and its fractions: assessment of Bcl-2 family expression in in vivo and ex vivo in rabbit models.J Venom Anim Toxins Incl Trop Dis2026https://conductscience.org/library/papers/42416494PubMed
42,248,141Xenophagocytosis blockade enhances interspecies chimerism.Cell2026https://conductscience.org/library/papers/42248141PubMed
42,213,242Regulated cell death programs shaping cancer therapy.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42213242PubMed
42,199,066Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets.Ann Med2026https://conductscience.org/library/papers/42199066PubMed
42,084,012A century of cell death research.J Cell Sci2026https://conductscience.org/library/papers/42084012PubMed
41,929,632Mechanistic overview and suggested strategies to overcome BCL-2 inhibitor resistance in TP53-mutated acute myeloid leukemia.Front Cell Dev Biol2026https://conductscience.org/library/papers/41929632PubMed
41,776,400The caspase gene family in Micropterus salmoides: genome-wide characterization, bioinformatics, and expression profiling analysis.BMC Genomics2026https://conductscience.org/library/papers/41776400PubMed
41,772,680Methyl-cantharidimide suppresses cyclin-dependent kinase 1 (CDK1) and induces oxeiptosis in liver cancer.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/41772680PubMed

1 to 10 of 814

See all 814 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596Swiss-Prot's referenceshttps://conductscience.org/library/genes/596NCBI Gene
IGHD3,495PubTator's text mininghttps://conductscience.org/library/genes/3495NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2250705

GET https://conductscience.org/api/papers/v1/2250705/cited_by?page=2